A new study found that weight-loss medications like Ozempic and Mounjaro are not as effective in a “real-world” setting ...

For patients with obesity initiating pharmacotherapy with semaglutide or tirzepatide, weight loss at one year is 8.7 percent ...

Diabetic weight loss medications are effective for people with schizophrenia without affecting psychotic symptoms, University ...

The following is a summary of “Oral semaglutide for the treatment of obesity: a retrospective real-world study,” published in ...

Variants of obesity-related genes influence how much weight patients lose on specific weight loss drugs like liraglutide, two studies report.

Experts say that semaglutide and tirzepatide can help patients with heart failure lose weight, but limited NHS access is ...

Researchers have identified the brain cells responsible for the weight-loss effects of semaglutide without triggering its undesirable side effects. This discovery paves the way for more targeted ...

Weight-loss drugs that mimic the effect of regulatory hormones on appetite and energy balance often come with a few rather ...

At the least, the new 7.2mg results point to scope for hiking the semaglutide dose in CagriSema to chase down that weight-loss target. The company is also running a phase 3b trial of 7.2mg ...

Patients taking weight-loss ... the eye condition. The semaglutide link was first suggested last year in a Harvard University study. “If patients experience a sudden loss of vision or rapidly ...

Few drugs have shifted public interest the way GLP-1 receptor agonists — like semaglutide and tirzepatide ... names thanks to their role in weight loss. But behind the headlines and hashtags ...

Recent advancements in weight-loss interventions ... the NHS issued guidance to stop pharmacists distributing Rybelsus (Semaglutide) to new patients, due to supply issues. This demand pressure ...